NCT06158113 Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06153355 A First-In-Human Study of LY3839840 in Healthy Participants Status COMPLETED Phase PHASE1
NCT06143956 A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight Status RECRUITING Phase PHASE2
NCT06132126 A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT06124807 A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight Status COMPLETED Phase PHASE2
NCT06119581 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06119529 A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis Status TERMINATED Phase PHASE1
NCT06111521 A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants Status COMPLETED Phase PHASE1
NCT06109311 A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor Status COMPLETED Phase PHASE3
NCT06104683 A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis Status WITHDRAWN Phase PHASE2
NCT06085079 Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study Status RECRUITING Phase PHASE4
NCT06075667 A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06074562 A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain Status COMPLETED Phase PHASE2
NCT06052462 A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT06049108 A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT06047548 A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities Status COMPLETED Phase PHASE3